NCT04460729 2020-12-03A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain MetastasesNovartisPhase 2 Withdrawn
NCT00055887 2013-05-10Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung CancerSpectrum Pharmaceuticals, IncPhase 3 Withdrawn